A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer

Yu Katayose, Kei Nakagawa, Tohru Onogawa, Hiroshi Yoshida, Fuyuhiko Motoi, Takeshi Naitoh, Toshiki Rikiyama, Shinichi Egawa, Michiaki Unno

Research output: Contribution to journalArticle

Abstract

As chemotherapy advances, patients who had liver metastases often come to receive liver resection after their chemotherapy, including oxaliplatin-based chemotherapy. We experienced a case of an acute hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based adjuvant chemotherapy, after neoadjuvant chemotherapy for liver metastases originating from colon cancer. There is a report that hypersensitivity reactions are frequent in the second course of the reintroduced-oxaliplatin-based regimen. It is thought that the prevention is necessary at the second course even if there is no significant symptom at the first course. Similar cases will increase as neoadjuvant therapies spread in the future; therefore, prescriptions for preventing hypersensitivity are necessary when administering reintroduced-oxaliplatin base chemotherapy.

Original languageEnglish
Pages (from-to)2651-2653
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume38
Issue number13
Publication statusPublished - 2011 Dec 15

Keywords

  • Allergie
  • HSR
  • Oxaliplatin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer'. Together they form a unique fingerprint.

  • Cite this